QUANTRO Therapeutics GmbH

Quantro and Boehringer Ingelheim Hit Milestone in Cancer Treatment Development

Quantro Therapeutics, which focuses on transcription factors targeting cancer treatments, announced that it has reached a key milestone in its joint R&D program with Boehringer Ingelheim.